We work at the convergence of science, medicine, and engineering to reinvent the process of drug discovery and treatment.

The Harvard Program in Therapeutic Science (HiTS) is an academic research and education program that advances the fundamental science underlying human diseases and drug discovery in order to improve patient care.


Our faculty, trainees, and staff study disease using innovative approaches that fuse laboratory investigation, clinical research, and computer science to accelerate the invention of the life-saving medicines and precision diagnostics that are needed to optimally treat individual patients.


HiTS brings together two approaches:

The Laboratory of Systems Pharmacology makes it possible to study the changes that promote disease and the ways in which therapeutic drugs function at the molecular level.

The Center for Regulatory Science focuses on evaluating drugs in clinical trials and balancing the benefits and risks of new medicines.

News, Events, & Updates

HiTS in the News

Seeing the Human Behind the Data

Read the article 

Regulatory Science Forum

From RegSci Classroom to Corporate Acquisition: The Story of HumanFirst

Andy Coravos, Managing Director at HumanFirst

May 7, 12:00pm ET